Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Lung Cancer

Naqash AR, et al. Cancer Immunol Immunother 2020.


The original version of this article unfortunately contained a mistake. The second sentence of the section "irAEs and ICI efficacy" should read as.